Back to Search
DANIEL BRUETMAN, MD
MD
Medical Oncology Physician
NPI: 1972583417IndividualAccepts Medicare
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
01054353A(IN)
Hematology & Oncology Physician
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
036072153(IL)
CMS Specialties
PrimaryHEMATOLOGY/ONCOLOGY
Education
OTHER
Class of 1983
Research & Publications (3)
Pemetrexed in second line and beyond small cell lung cancer: a Hoosier Oncology Group phase II study.
PMID 19096313·J Thorac Oncol·2009
3-trial
Phase III study of cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel in patients with inoperable stage III non-small-cell lung cancer: the Hoosier Oncology Group and U.S. Oncology.
PMID 19001323·J Clin Oncol·2008
3-trial
Gefitinib plus celecoxib in chemotherapy-naïve patients with stage IIIB/IV non-small cell lung cancer: a phase II study from the Hoosier Oncology Group.
PMID 18379355·J Thorac Oncol·2008
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- OUTPATIENT CARE CENTER DOWNTOWN CHICAGO, 160 E. ILLINOIS STREET
CHICAGO, IL 60611 - Phone
- (312) 477-2400
Quick Facts
- NPI
- 1972583417
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 43
- Publications
- 3
Are you this provider?
Claim Your Profile